Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Donor's graft ex vivo T-cell depletion with fludarabine reduces graft-versus-host disease signs and improves survival after intestinal transplantation - an experimental study.
Vela M, Stringa P, González-Navarro P, Machuca M, Pascual-Miguel B, Mestre C, Arreola NM, Papa-Gobbi R, Navarro-Zapata A, Pires-Lobo SC, Andrés AM, Hernández-Oliveros F, Pérez-Martínez A. Vela M, et al. Among authors: pascual miguel b. Transpl Int. 2020 Oct;33(10):1302-1311. doi: 10.1111/tri.13672. Epub 2020 Jul 16. Transpl Int. 2020. PMID: 32526809 Free article.
Novel coronavirus (SARS-CoV-2) infection in a patient with multivisceral transplant.
Papa-Gobbi R, Bueno A, Serradilla J, Talayero P, Stringa P, Pascual-Miguel B, Alcolea-Sánchez A, González-Sacristan R, Andrés AM, López-Santamaría M, Rumbo M, Ramos-Boluda E, Hernández-Oliveros F. Papa-Gobbi R, et al. Among authors: pascual miguel b. Transpl Infect Dis. 2021 Feb;23(1):e13430. doi: 10.1111/tid.13430. Epub 2020 Aug 8. Transpl Infect Dis. 2021. PMID: 32741047 Free PMC article. No abstract available.
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy.
Ferreras C, Pascual-Miguel B, Mestre-Durán C, Navarro-Zapata A, Clares-Villa L, Martín-Cortázar C, De Paz R, Marcos A, Vicario JL, Balas A, García-Sánchez F, Eguizabal C, Solano C, Mora-Rillo M, Soria B, Pérez-Martínez A. Ferreras C, et al. Among authors: pascual miguel b. Front Cell Dev Biol. 2021 Feb 25;9:620730. doi: 10.3389/fcell.2021.620730. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33718360 Free PMC article.
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE).
Pérez-Martínez A, Mora-Rillo M, Ferreras C, Guerra-García P, Pascual-Miguel B, Mestre-Durán C, Borobia AM, Carcas AJ, Queiruga-Parada J, García I, Sánchez-Zapardiel E, Gasior M, De Paz R, Marcos A, Vicario JL, Balas A, Moreno MA, Eguizabal C, Solano C, Arribas JR, Buckley RM, Montejano R, Soria B. Pérez-Martínez A, et al. Among authors: pascual miguel b. EClinicalMedicine. 2021 Sep;39:101086. doi: 10.1016/j.eclinm.2021.101086. Epub 2021 Aug 13. EClinicalMedicine. 2021. PMID: 34405140 Free PMC article.
Donor selection for adoptive cell therapy with CD45RA- memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release.
Al-Akioui-Sanz K, Pascual-Miguel B, Díaz-Almirón M, Mestre-Durán C, Navarro-Zapata A, Clares-Villa L, Martín-Cortázar C, Vicario JL, Moreno MÁ, Balas A, De Paz R, Minguillón J, Pérez-Martínez A, Ferreras C. Al-Akioui-Sanz K, et al. Among authors: pascual miguel b. Cytotherapy. 2023 Mar;25(3):330-340. doi: 10.1016/j.jcyt.2022.12.001. Epub 2022 Dec 12. Cytotherapy. 2023. PMID: 36585293 Free PMC article.